ECOR Executive Compensation

* In USD (Original Currency)
Filing Date
(SEC Report)
Year Reporting Name Salary Bonus Stock Award Incentive Plan Compensation Other Compensation Total
2023-06-05 2021 Daniel S. Goldberger Chief Executive Officer 525,000 262,000 0 0 23,670 1,304,339
2023-06-05 2022 Daniel S. Goldberger Chief Executive Officer 556,500 278,250 0 0 25,943 997,605
2023-06-05 2021 Brian Posner Chief Financial Officer 365,000 146,000 0 0 23,280 835,455
2023-06-05 2022 Brian Posner Chief Financial Officer 387,000 154,800 0 0 18,260 614,830
2022-10-11 2020 Daniel S. Goldberger Chief Executive Officer 500,000 300,000 0 0 119,637 919,636
2022-10-11 2021 Daniel S. Goldberger Chief Executive Officer 525,000 262,000 0 0 23,670 1,304,838
2022-10-11 2020 Brian Posner Chief Financial Officer 341,667 238,000 0 0 21,950 698,270
2022-10-11 2021 Brian Posner Chief Financial Officer 365,000 146,000 0 0 23,280 835,455
2021-04-26 2020 Daniel S. Goldberger Chief Executive Officer 500,000 300,000 0 0 119,637 919,636
2021-04-26 2020 Brian Posner Chief Financial Officer 341,667 238,000 0 0 21,950 698,270
2021-04-26 2019 Brian Posner Chief Financial Officer 263,541 100,000 130,000 0 16,996 1,129,013
2021-04-26 2019 Daniel S. Goldberger Chief Executive Officer 125,000 62,500 400,000 0 0 1,789,433
2020-04-27 2019 Daniel S. Goldberger Chief Executive Officer 125,000 62,500 400,000 0 0 1,789,433
2020-04-27 2018 Daniel S. Goldberger Chief Executive Officer 0 0 0 0 0 0
2020-04-27 2019 Brian Posner Chief Financial Officer 263,541 100,000 130,000 0 16,996 1,129,013
2020-04-27 2018 Brian Posner Chief Financial Officer 0 0 0 0 0 0
2020-04-27 2019 Francis R. Amato Former Chief Executive Officer 1,134,375 0 735,846 0 48,264 3,487,907
2020-04-27 2018 Francis R. Amato Former Chief Executive Officer 446,125 250,000 0 150,000 20,395 1,354,020
2020-04-27 2019 Joseph P. Errico Former Chief Science and Strategy Officer 753,916 0 172,744 0 22,368 1,467,123
2020-04-27 2018 Joseph P. Errico Former Chief Science and Strategy Officer 389,792 125,000 0 150,000 20,395 1,127,187
2020-04-27 2019 Peter S. Staats, MD Chief Medical Officer 72,919 0 464,857 0 165,496 1,205,128
2020-04-27 2018 Peter S. Staats, MD Chief Medical Officer 338,333 105,000 0 0 20,395 723,728
2019-04-30 2017 Peter S. Staats, M.D. Former Chief Medical Officer 151,667 10,000 0 0 6,820 198,487
2019-04-30 2018 Peter S. Staats, M.D. Former Chief Medical Officer 338,333 105,000 0 0 20,395 723,728
2019-04-30 2017 Joseph P. Errico Chief Science & Strategy Officer, Director 350,000 70,000 0 0 16,369 541,207
2019-04-30 2018 Joseph P. Errico Chief Science & Strategy Officer, Director 389,792 125,000 0 150,000 20,395 1,127,187
2019-04-30 2017 Francis R. Amato Chief Executive Officer, Director 400,000 70,000 0 125,000 16,369 767,838
2019-04-30 2018 Francis R. Amato Chief Executive Officer, Director 446,125 250,000 0 150,000 20,395 1,354,020

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.